Foresite Capital Management III’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-998,278
Closed -$5.11M 7
2021
Q3
$5.11M Hold
998,278
7.09% 5
2021
Q2
$8.3M Hold
998,278
8.79% 4
2021
Q1
$8.7M Hold
998,278
7.64% 6
2020
Q4
$10.8M Hold
998,278
12.6% 5
2020
Q3
$11.9M Hold
998,278
8.87% 5
2020
Q2
$16M Buy
998,278
+284,466
+40% +$4.57M 14.26% 4
2020
Q1
$11.1M Buy
713,812
+26,385
+4% +$409K 17.63% 2
2019
Q4
$16.9M Sell
687,427
-310,851
-31% -$7.65M 9.48% 4
2019
Q3
$10.3M Hold
998,278
3.93% 8
2019
Q2
$12.5M Hold
998,278
4.11% 8
2019
Q1
$12.4M Buy
998,278
+63
+0% +$781 3.22% 10
2018
Q4
$6.15M Buy
998,215
+80,500
+9% +$496K 2.02% 13
2018
Q3
$9.73M Sell
917,715
-22,970
-2% -$243K 2.15% 14
2018
Q2
$12.7M Sell
940,685
-57,593
-6% -$780K 2.74% 11
2018
Q1
$17.7M Hold
998,278
3.86% 11
2017
Q4
$12.5M Buy
998,278
+148,585
+17% +$1.86M 3.52% 9
2017
Q3
$16.2M Buy
849,693
+50,330
+6% +$959K 4.46% 8
2017
Q2
$12.1M Buy
799,363
+117,441
+17% +$1.77M 3.94% 8
2017
Q1
$11.7M Buy
681,922
+76,683
+13% +$1.32M 4.49% 6
2016
Q4
$7.32M Sell
605,239
-6,538
-1% -$79.1K 3.18% 10
2016
Q3
$6.02M Buy
611,777
+100,000
+20% +$984K 2.81% 10
2016
Q2
$5.24M Buy
511,777
+35,000
+7% +$358K 3.6% 7
2016
Q1
$5.78M Buy
476,777
+15,126
+3% +$183K 4.47% 6
2015
Q4
$7.4M Buy
+461,651
New +$7.4M 6.56% 4